rs3746802
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_033409.4(SLC52A3):āc.907A>Gā(p.Ile303Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.107 in 1,614,092 control chromosomes in the GnomAD database, including 9,708 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.094 ( 711 hom., cov: 33)
Exomes š: 0.11 ( 8997 hom. )
Consequence
SLC52A3
NM_033409.4 missense
NM_033409.4 missense
Scores
3
4
11
Clinical Significance
Conservation
PhyloP100: 7.92
Genes affected
SLC52A3 (HGNC:16187): (solute carrier family 52 member 3) This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0028273165).
BP6
Variant 20-763664-T-C is Benign according to our data. Variant chr20-763664-T-C is described in ClinVar as [Benign]. Clinvar id is 262241.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-763664-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.127 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0940 AC: 14294AN: 152106Hom.: 709 Cov.: 33
GnomAD3 genomes
AF:
AC:
14294
AN:
152106
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.103 AC: 25862AN: 251384Hom.: 1454 AF XY: 0.107 AC XY: 14515AN XY: 135880
GnomAD3 exomes
AF:
AC:
25862
AN:
251384
Hom.:
AF XY:
AC XY:
14515
AN XY:
135880
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.109 AC: 158688AN: 1461868Hom.: 8997 Cov.: 35 AF XY: 0.109 AC XY: 79544AN XY: 727234
GnomAD4 exome
AF:
AC:
158688
AN:
1461868
Hom.:
Cov.:
35
AF XY:
AC XY:
79544
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0940 AC: 14306AN: 152224Hom.: 711 Cov.: 33 AF XY: 0.0938 AC XY: 6982AN XY: 74416
GnomAD4 genome
AF:
AC:
14306
AN:
152224
Hom.:
Cov.:
33
AF XY:
AC XY:
6982
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
408
ALSPAC
AF:
AC:
441
ESP6500AA
AF:
AC:
347
ESP6500EA
AF:
AC:
943
ExAC
AF:
AC:
12782
Asia WGS
AF:
AC:
525
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 23, 2017 | p.Ile303Val in exon 3 of SLC52A3: This variant is not expected to have clinical significance because it has been identified in 13.79% (2277/16510) of South Asia n chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstit ute.org; dbSNP rs3746802). - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 01, 2018 | This variant is associated with the following publications: (PMID: 22471455) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Progressive bulbar palsy of childhood;C0796274:Brown-Vialetto-van Laere syndrome 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 30, 2022 | - - |
Brown-Vialetto-van Laere syndrome 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T;T
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;.;T;.;T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M;M;M;M
PrimateAI
Uncertain
T
PROVEAN
Benign
.;.;N;N;.
REVEL
Uncertain
Sift
Benign
.;.;T;T;.
Sift4G
Benign
.;T;T;T;.
Polyphen
D;D;D;D;D
Vest4
0.23, 0.28, 0.23
MPC
0.71
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at